Nutritional effects of fat on carbohydrate metabolism

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 17, Issue 3, 2003, Pages 399-410

  Boden, Guenther ^a   Carnell, Laura H ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerotic vascular disease; Free fatty acids; Insulin resistance; Insulin secretion; Obesity

Indexed keywords

ACIPIMOX; CARBOHYDRATE; DIACYLGLYCEROL; FAT; FATTY ACID; GLUCOSE; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; ISOPROTEIN; PLACEBO; PROTEIN KINASE C; SERINE; TRIACYLGLYCEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CELLULAR DISTRIBUTION; CLINICAL RESEARCH; DIABETES MELLITUS; DISEASE PREDISPOSITION; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE TOLERANCE; GLYCOGENOLYSIS; HORMONE INHIBITION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL HEALTH; NUTRITIONAL VALUE; OBESITY; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL PROCESSING; SKELETAL MUSCLE; TREATMENT PLANNING; WEIGHT REDUCTION; B LYMPHOCYTE; DISEASE COURSE; LIPID METABOLISM; LIVER METABOLISM; MUSCLE METABOLISM; NUTRITION; SIGNAL TRANSDUCTION;

EID: 0141455223     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-690X(03)00032-0     Document Type: Review

References (59)

1. Dietary Reference Intakes for Energy Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids, Part I. Washington: The National Academies Press, 2002. p. 866.
2. Pascoe WS & Storlien LH. Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function: Model for study of etiology and pathogenesis of NIDDM. Diabetes 1990; 39: 226-233.
3. Sims EAH, Danforth Jr. E, Horton ES et al. Endocrine and metabolic effects of experimental obesity in man. Recent Progress in Hormone Research 1973; 29: 457-496.
4. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10.
5. Kelley DE, Mokan M, Simoneau J-A & Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. Journal of Clinical Investigation 1993; 92: 91-98.
6. DeFronzo RA, Jacot E, Jequier E et al. The effect of insulin on the disposal of intravenous glucose: Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30: 1000-1007.
7. Boden G, Jadali F, White J et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. Journal of Clinical Investigation 1991; 88: 960-966.
8. Boden G, Chen X, Ruiz J, White JV & Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. Journal of Clinical Investigation 1994; 93: 2438-2446.
9. Shah P, Vella A, Basu A et al. Elevated free fatty acids impair glucose metabolism in women. Decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes 2003; 52: 38-42.
10. Homko CJ, Cheung P & Boden G. Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes 2003; 52: 487-491.
11. Roden M, Price TB, Perseghin G et al. Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 1996; 97: 2859-2865.
12. Sivan E, Homko CJ, Whittaker PG et al. Free fatty acids and insulin resistance during pregnancy. Journal of Clinical Endocrinology and Metabolism 1998; 83: 2338-2342.
13. Boden G & Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin dependent diabetes. Journal of Clinical Investigation 1995; 96: 1261-1268.
14. Santomauro A, Boden A, Silva M et al. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and non-diabetic subjects. Diabetes 1999; 48: 1836-1841.
15. Frias JP, Macaraeg GB, Frecio J et al. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 2001; 50: 1344-1350.
16. Boden G, Chen X & Stein TP. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. American Journal of Physiology 2001; 280: E23-E30.
17. DeFronzo RA, Simonson D & Ferrannini E. Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type I (insulin-dependent) diabetes mellitus. Diabetologia 1982; 23: 313-319.
18. Jeng CY, Sheu WH, Fuh MM et al. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes 1994; 43: 1440-1444.
19. Williamsson JR, Kreisberg RA & Felts PW. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proceedings of the National Academy of Sciences of the USA 1966; 6: 247-254.
20. Roden M, Stingl H, Chandramouli V et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 2000; 49: 701-701.
21. Chen X, Iqbal N & Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. Journal of Clinical Investigation 1999; 103: 365-372.
22. Boden G, Chen X, Capulong E & Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 2001; 50: 810-816.
23. Crespin SR, Greenough WB & Steinberg D. Stimulation of insulin secretion by long-chain free fatty acids. Journal of Clinical Investigation 1973; 52: 1979-1984.
24. Gastaldelli A, Toschi E, Pettiti M et al. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 2001; 50: 1807-1812.
25. Boden G, Cheung P, Stein TP et al. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. American Journal of Physiology 2002; 283: E12-E19.
26. Boden G, Cheung P & Homko C. Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type I diabetes. Diabetes 2003; 52: 133-137.
27. Edgerton DS, Carin S, Emshwiller M et al. Small increases in insulin inhibit hepatic glucose production solely caused by an effect of glycogen metabolism. Diabetes 2001; 50: 1872-1882.
28. Bevilacqua S, Buzzigoli G, Bonadonna R et al. Operation of Randle's cycle in patients with NIDDM. Diabetes 1990; 39: 383-389.
29. Saloranta C, Koivisto V, Widen E et al. Contribution of muscle and liver to glucose-fatty acid cycle in humans. American Journal of Physiology 1993; 264: E599-E605.
30. Ferrannini E, Barrett E, Bevilacqua S & DeFronzo R. Effect of fatty acids on glucose production and utilization in man. Journal of Clinical Investigation 1983; 72: 1737-1747.
31. Fanelli C, Calderone S, Epifano L et al. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. Journal of Clinical Investigation 1993; 92: 1617-1622.
32. Felber JP & Vanotti A. Effects of fat infusions on glucose tolerance and insulin plasma levels. Medicina Experimentalis 1964; 10: 153-156.
33. Pelkonen R, Miettinen A, Taskinen M.-R & Nikkila EA. Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes 1968; 17: 76-82.
34. Malaisse WJ, Malaisse-Lagae F. Stimulation of insulin secretion by non-carbohydrate metabolites. Journal of Laboratory Clinical Medicine 1968; 72: 438-448.
35. Goberna RJ, Tamarit Jr. J, Fussganger R et al. Action of β-hydroxybutyrate, acetoacetate and palmitate on the insulin release from the perfused isolated rat pancreas. Hormone and Metabolic Research 1974; 6: 256-260.
36. Sako Y & Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990; 127: 1580-1589.
37. Zhou Y.-P & Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. Journal of Clinical Investigation 1994; 93: 870-876.
38. Bollheimer LC, Skelly RH, Chester MW et al. Chronic exposure to free fatty acids reduced pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. Journal of Clinical Investigation 1998; 101: 1094-11081.
39. Boden G, Chen X, Rosner J et al. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 1995; 44: 1239-1242.
40. Boden G, Chen X & Iqbal N. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes 1998; 47: 1609-1612.
41. Boden G & Chen X. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Diabetes 1999; 48: 577-583.
42. Hirose H, Lee YH, Inman LR et al. Defective fatty acid mediated β-cell compensation in Zucker diabetic fatty rats. Journal of Biological Chemistry 1996; 271: 5633-5637.
43. Dresner A, Laurent D, Marcucci M et al. Effects of free fatty acids on glucose transport and IRS-I-associated phosphatidylinositol 3-kinase activity. Journal of Clinical Investigation 1999; 103: 253-259.
44. Kahn BB. Lilly lecture. Glucose transport: Pivotal step in insulin action. Diabetes 1996; 45: 1644-1654.
45. Pan DA, Lillioja S, Kriketos AD et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997; 45: 983-988.
46. Koyama K, Chen G, Lee Y & Unger RH. Tissue triglycerides, insulin resistance, and insulin production: Implications for hyperinsulinemia of obesity. American Journal of Physiology 1997; 273: E708-E713.
47. Oakes ND, Cooney GJ, Camilleri S et al. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 1997; 46: 1768-1774.
48. Boden G, Lebed B, Schatz M et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50: 1612-1617.
49. Schmitz-Peiffer C, Browne CL, Oakes ND et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997; 46: 169-178.
50. Itani SI, Ruderman NB, Schmieder F & Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 2002; 51: 2005-2011.
51. Farese R. In: Le Port D et al (eds) Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia: Lippincott, 2000, pp 239-251.
52. Griffin ME, Marcucci MJ, Cline GW et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C Θ and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270-1274.
53. Ravichandran LV, Esposito DL, Chen J & Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-I and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. Journal of Biological Chemistry 2001; 276: 3543-3549.
54. Gao Z, Hwang D, Bataille F et al. Serine phosphorylation of insulin receptor substrate I by inhibitor κB kinase complex. Journal of Biological Chemistry 2002; 277: 48115-48121.
55. Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-I (IRS-I)-associated phosphatidylinositol 3-kinase activity in muscle. Journal of Biological Chemistry 2002; 277: 50230-50236.
56. Lam TKT, Yoshi H, Haber A et al. Free fatty acid-induced hepatic insulin resistance: A potential role for protein kinase C-δ. American Journal of Physiology 2002; 283: E682-E691.
57. Boden G. Fuel metabolism in pregnancy and in gestational diabetes mellitus. Obstetrics and Gynecology Clinics of North America 1996; 23: 1-10.
58. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
59. Ross R. Atherosclerosis: An inflammatory disease. New England Journal of Medicine 1999; 34: 115-120.